NAD+-Boosting Ameliorates Heme Protein-Mediated Acute Kidney Injury
Kidney360 · 2025
DOI: 10.34067/kid.0000001032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, 2025. Verfasst von Raman Deep Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Acute Kidney Injury, NAD, Hemeproteins, Kidney. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Background
Understanding how heme proteins and heme induce AKI is clinically relevant from numerous perspectives, and, in this regard, a widely used model of heme protein-mediated (HP-AKI) involves the glycerol model in mice. Using this model, we have previously demonstrated that NAD + content is decreased in HP-AKI. As there is significant current interest in NAD + -boosting as a strategy in clinical AKI, we examined the effect of NAD + -boosting in this model.
Methods
NAD + -boosting was achieved by the administration of nicotinamide mononucleotide (NMN) in the glycerol model of HP-AKI. The effect of NMN, compared with vehicle, was examined in mice with HP-AKI and with sham AKI at day 1 after HP-AKI was induced.
Results
The administration of NMN preserved kidney NAD + content in HP-AKI and, compared with the administration of vehicle in HP-AKI, NMN improved glomerular filtration markers; reduced histologic injury as assessed by tubular necrosis, dilation, and cast formation and by assessment of dystrophic calcification; reduced expression of KIM1, a sensitive marker of AKI; preserved mitochondrial ultrastructure and increased expression of proteins that promote mitochondrial integrity; reduced apoptosis as assessed by TUNEL staining and genes and protein expression that contribute to apoptosis, while increasing expression of an anti-apoptotic gene; reduced expression of several renal injury-related genes; and mitigated the severity of the senescence phenotype, as assessed by multiple markers. Finally, the administration of myoglobin or heme in vivo diminished kidney NAD + content in mice with intact kidneys.
Conclusions
These findings demonstrate the remarkable protective effects of NAD + -boosting by NMN in HP-AKI as revealed by a multitude of markers relevant to AKI. The reduction in NAD + content in the kidney in HP-AKI may reflect the direct effects of heme proteins and/or heme. We suggest that these findings support current interest in NAD + -boosting as a therapeutic strategy in clinical AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
- Microscopy and Cell Analysis Core Facility, Mayo Clinic, Rochester, Minnesota.
- Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
- Medical Affairs, FME Global Medical Office Waltham, Massachusetts.
ORCID-Profile: Raman Deep Singh, Joseph P Grande, Trace A Christensen, Luis A Juncos, Karl A Nath
Förderung
- NIDDK NIH HHS
Zitieren
APA
Singh, R. D., Croatt, A. J., Grande, J. P., Ackerman, A. W., Christensen, T. A., Juncos, L. A., & Nath, K. A. (2025). NAD+-Boosting Ameliorates Heme Protein-Mediated Acute Kidney Injury. Kidney360. https://doi.org/10.34067/kid.0000001032
Vancouver
Singh RD, Croatt AJ, Grande JP, Ackerman AW, Christensen TA, Juncos LA, et al. NAD+-Boosting Ameliorates Heme Protein-Mediated Acute Kidney Injury. Kidney360. 2025. doi:10.34067/kid.0000001032
BibTeX
@article{Singh2025,
author = {Singh, Raman Deep and Croatt, Anthony J and Grande, Joseph P and Ackerman, Allan W and Christensen, Trace A and Juncos, Luis A and Nath, Karl A},
title = {NAD+-Boosting Ameliorates Heme Protein-Mediated Acute Kidney Injury},
journal = {Kidney360},
year = {2025},
doi = {10.34067/kid.0000001032}
}
EUVIMED